2,000
Participants
Start Date
December 31, 2004
Primary Completion Date
November 30, 2006
Study Completion Date
March 31, 2007
Point of Care cTnL testing
"The study design will be a phase IV prospective, randomized (1:1), parallel-group trial utilizing concurrent controls. The experimental group of interest will be patients receiving the POC cTnI test, and the control group will be patients receiving the central laboratory cTnI test.~The treating physician will be blinded to the randomization and will receive only the POC results from half the study patients and only the laboratory results for the remaining half."
The Jewish Hospital, Cincinnati
William Beaumont Hospital, Royal Oak
Stanford University, Stanford
The University of Pennsylvania, Philadelphia
Collaborators (2)
Abbott
INDUSTRY
Jewish Hospital, Cincinnati, Ohio
OTHER
University of Pennsylvania
OTHER
Stanford University
OTHER
Mayo Clinic
OTHER
University of Cincinnati
OTHER